Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

Thyroglobulin (Tg) is fundamental for differentiated thyroid cancer (DTC) monitoring. Tg detection can be enhanced using recombinant human thyroid-stimulating hormone (TSH) (rhTSH). This study is aimed to evaluate the use of the rhTSH stimulation test when using a high-sensitivity Tg assay.

Bibliographic Details
Main Authors:	Sandúa Amaia, Macias Monica, Perdomo Carolina, Galofre Juan Carlos, Ferrer Roser, Alegre Estibaliz, González Álvaro
Format:	Article
Language:	English
Published:	De Gruyter 2020-01-01
Series:	Advances in Laboratory Medicine
Subjects:	differentiated thyroid cancer rhtsh stimulation test thyroglobulin antithyroglobulin antibodies thyroidectomy
Online Access:	https://doi.org/10.1515/almed-2019-0017

Similar Items

Clinical significance of thyroglobulin autoantibodies enhancement in patients with differentiated thyroid cancer after thyroidectomy and radioiodine therapy
Published: (2013-09-01)

Measuring thyroglobulin concentrations in patients with differentiated thyroid carcinoma
by: Savin Svetlana, et al.
Published: (2010-01-01)

Utilidad del test de TSH recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides según los resultados de tiroglobulina basal
by: Sandúa Amaia, et al.
Published: (2020-03-01)

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma
by: Yushen Gu, et al.
Published: (2021-02-01)

Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid Cancer
by: Justus Baumgarten, et al.
Published: (2022-05-01)

Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of 131I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study
by: Mengjiao Pan, et al.
Published: (2022-04-01)

Predictive factors for longer operative times for thyroidectomy
by: Hee Yong Kwak, et al.
Published: (2017-03-01)

Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
by: Hashem O. Zahra, et al.
Published: (2021-11-01)

The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature
by: Evangelos Karvounis, et al.
Published: (2021-01-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study
by: Xiaomeng Jia, et al.
Published: (2020-07-01)

Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer
by: Kim Magaly Pabst, et al.
Published: (2023-01-01)

Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy
by: Sheng-Fong Kuo, et al.
Published: (2017-05-01)

Poly (lactic-co-glycolic acid)-encapsulated iodine-131 nanoparticles fabricated with rhTSH induce apoptosis and immobilization of thyroid cancer cells
by: Yongzeng Fan, et al.
Published: (2023-01-01)

Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
by: Nan Jiang, et al.
Published: (2023-12-01)

Rare Metastases from a Papillary Thyroid Carcinoma
by: Deepak Rathinam, et al.
Published: (2017-08-01)

Determining the frequency of thyroid parameter measurements following rhTSH administration in a healthy, older population
by: Ana Zutinic, et al.
Published: (2021-01-01)

Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
by: Adriano Francisco De Marchi Junior, et al.
Published: (2021-07-01)

Elevated thyroglobulin level is associated with dysfunction of regulatory T cells in patients with thyroid nodules
by: Yun Hu, et al.
Published: (2019-03-01)

Pre-Ablation Thyroglobulin Levels and Persistence / Recurrence Associated to Early Differentiated Thyroid Cancer
by: Arturo Mejía López, et al.
Published: (2014-01-01)

Zdravljenje metastatskega diferenciranega raka ščitnice z radiojodom ob rhTSH
by: Ivana Žagar
Published: (2009-06-01)

Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo
by: Yifen Yang, et al.
Published: (2014-01-01)

The influence of thyroid status, serum Tg, TSH, and TgAb on FNA‐Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma
by: Jingjing Sun, et al.
Published: (2022-02-01)

Reactivity of anti-thyroid antibodies to thyroglobulin tryptic fragments: comparison of autoimmune and non-autoimmune thyroid diseases
by: L.H.B. Boechat, et al.
Published: (1999-04-01)

Analysis of malignancy predictors for follicular thyroid tumors
by: Zorić Goran V., et al.
Published: (2020-01-01)

Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital
by: Sarah E. Wheeler, et al.
Published: (2017-12-01)

Importance of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in detection of post-thyroidectomy recurrence in differentiated thyroid cancer with negative radio-isotope iodine scan, yet, elevated serum thyroglobulin level
by: Amir Fathy Henfy Younis, et al.
Published: (2022-05-01)

Study of thyroid disorders in vitiligo
by: Lalchamliani Khiangte, et al.
Published: (2023-01-01)

Canonical TSH Regulation of Cathepsin-Mediated Thyroglobulin Processing in the Thyroid Gland of Male Mice Requires Taar1 Expression
by: Maria Qatato, et al.
Published: (2018-03-01)

The role of thyroglobulin doubling time in differentiated thyroid cancer: a meta-analysis
by: Luca Giovanella, et al.
Published: (2022-04-01)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
by: Yanli Ju, et al.
Published: (2023-01-01)

Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma
by: Alberto Signore, et al.
Published: (2023-05-01)

Coexistence of Hashimoto’s Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response
by: Alessandra Donnici, et al.
Published: (2024-01-01)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
by: Luis Felipe Zavala, et al.
Published: (2019-04-01)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
by: Szabina Szujo, et al.
Published: (2021-01-01)

Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer
by: Tse-Ying Huang, et al.
Published: (2020-06-01)

Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study
by: Na Han, et al.
Published: (2023-09-01)

Breast Cancer and Autoimmune Thyroid Disease Relationship: Can Hormonal Factors or Thyroglobulin Gene Polymorphism Be the Common Factor?
by: Tolga Özmen, et al.
Published: (2014-01-01)

The Role of Intraoperative Thyroglobuline Level of Lymph Node in the Management of Papillary Thyroid Cancer (Determination of a Cutoff Point)
by: Mohsen Kolahdouzan, et al.
Published: (2017-01-01)